Acquired atrophy of ovary, unspecified side
ICD-10 N83.319 is a billable code used to indicate a diagnosis of acquired atrophy of ovary, unspecified side.
Acquired atrophy of the ovary refers to the reduction in size and function of the ovarian tissue, which can occur due to various factors such as hormonal imbalances, surgical interventions, or chronic conditions affecting the reproductive system. This condition may be associated with endometriosis, where ectopic endometrial tissue can lead to inflammation and damage to ovarian tissue. Additionally, female genital prolapse can contribute to altered pelvic anatomy, potentially impacting ovarian function. Fistulas, particularly those involving the reproductive tract, may also lead to complications that affect ovarian health. Ovarian disorders, including polycystic ovary syndrome (PCOS) and premature ovarian failure, can further complicate the clinical picture. The atrophy may be unilateral or bilateral, but in this case, it is unspecified, indicating that the documentation does not specify which ovary is affected. Clinicians must consider the patient's overall reproductive health and any underlying conditions when diagnosing and managing acquired atrophy of the ovary.
Detailed patient history, physical examination findings, imaging results, and any surgical notes.
Patients presenting with pelvic pain, abnormal menstrual cycles, or infertility.
Ensure clear documentation of any associated conditions and the specific clinical context of ovarian atrophy.
Hormonal assay results, imaging studies, and comprehensive reproductive history.
Patients with hormonal imbalances, infertility issues, or polycystic ovary syndrome.
Documenting the impact of hormonal therapies or interventions on ovarian function is crucial.
Used in conjunction with N83.319 when surgical intervention is performed for endometriosis-related ovarian atrophy.
Operative report detailing the procedure and findings.
Ensure that the diagnosis of ovarian atrophy is clearly linked to the surgical intervention.
Specifying the side affected by ovarian atrophy is crucial for accurate coding and treatment planning, as it can influence management strategies and surgical decisions.
